Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 29, 2020

View Archived Issues

Pigs with NLRP3 gain-of-function mutation mimic the pathogenesis of human CAPS

Transgenic mice allow study of erythroferrone overexpression

IMV provides update on the development of DPX-COVID-19

CART-Ddbcma leads to rapid and durable responses in relapsed/refractory multiple myeloma

KIAA1429 as potential prognostic biomarker in DLBCL

Janssen describes new PD-L1 antagonists

Istituto Europeo di Oncologia and IFOM patent NEDD-4 inhibitors

Boehringer Ingelheim identifies NMDA NR2B receptor negative allosteric modulators

China Pharmaceutical University, SIMM disclose E-FABP/A-FABP inhibitors

CYAD-211 demonstrates antitumor efficacy in xenograft models of multiple myeloma

New acetyl-CoA carboxylase inhibitors discovered at Almirall

Lynparza approved in Japan for ovarian, prostate and pancreatic cancer

Novavax initiates phase III trial of NVX-CoV2373 COVID-19 vaccine candidate in U.S. and Mexico

Arcturus cleared to begin phase II study of COVID-19 vaccine candidate ARCT-021

New CTP synthase 1 inhibitors described by Step Pharma

Universitaet Regensburg, Universitaet zu Koeln present CD25-specific CAR

Redwood reports further phase II data analysis on RP-101 for dry eye

Celltrion seeks conditional marketing authorization in Korea for CT-P59

Novel mouse model carries mouse homologue of X-linked neutropenia WASp mutation I290T

Lysogene reports biomarker data from AAVance trial of LYS-SAF-302 for MPS IIIA

Condensates open new vistas in cell biology, therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...